Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2013

Prima BioMed Ltd. (PBMD) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

Prima BioMed Ltd. is a biotechnology company focused on researching and commercializing licensed medical products throughout Australia. Its immunotherapy products include oncology therapies, and its current lead product is a cancer vaccine for patients in remission. Other products include its … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

OXiGENE, Inc. (OXGN) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

OXiGENE is a San Francisco-based biopharmaceutical company focused on cancer treatment therapies. The company’s products are designed to destroy the abnormal blood vessels that act as a lifeline to developing cancerous tumors. Several of its therapies have reached Phase II … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

Calpian, Inc. (CLPI) Says Money-on-Mobile Achieves Sequential Growth, Reaches Nearly 68 Million Users

Posted on September 9, 2013 by MissionIR

Calpian, a U.S.-based company focused on mobile payments emerging-market operations through its subsidiary in India, today reports that as of August 31, 2013, the Money-on-Mobile (MOM) service offered by its Indian subsidiary is available now at 157,860 retail locations, an … Continue reading →

Posted in Calpian Inc. CLPI | Leave a comment

Aeterna Zentaris, Inc. (AEZS) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

Aeterna Zentaris is a specialty biopharmaceutical company with its focus on developing novel treatments in oncology and endocrinology. The company’s pipeline encompasses compounds from drug discovery to regulatory approval. Its lead drug development programs include zoptarelin doxorubicin (AEZS-108), a hybrid … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

Synthesis Energy Systems (SYMX) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

Synthesis Energy Systems delivers green chemical solutions to companies using its ability to convert feedstocks such as refuse-derived fuels, municipal solid wastes, shredder residue, and agricultural waste materials. With the application of its licensed UGAS technology, Synthesis Energy Systems provides … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

NeoStem, Inc. (NBS) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

NeoStem is a New York City-based cell therapy company that engages in the development of proprietary therapy products. The company offers cell product and process development, cell and tissue processing, regulatory support, storage, distribution and deliver, and consulting services to … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

Chimera Investment Corporation (CIM) Video Chart for Monday, September 9, 2013

Posted on September 9, 2013 by MissionIR

CIM is holding a support at $2.95. Friday’s upward move has the chart positioned to potentially take a run at some resistance at $3.08 and then top-end resistance at $3.24, which would represent multi-year highs. To view the video chart, … Continue reading →

Posted in Technical Analysis | Leave a comment

Protalex, Inc. (PRTX) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

Protalex is a drug development company currently working to treat autoimmune inflammatory diseases in patients in the United States. Its biopharmaceutical products target diseases, such as rheumatoid arthritis, by binding to and regulating the cells that may compromise healthy cells … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

PharmAthene, Inc. (PIP) Starts Presentation at Rodman & Renshaw Global Investment Conference

Posted on September 9, 2013 by MissionIR

PharmAthene is a biodefense company headquartered in Annapolis, MD, which positions it conveniently close to the United States Department of Defense, its primary client. The company engages in the development and commercialization of medical solutions to biological and chemical threats. … Continue reading →

Posted in Rodman and Renshaw Conference | Leave a comment

LipoScience, Inc. (LPDX) Appoints William Cromwell as Chief Medical Officer

Posted on September 9, 2013 by MissionIR

LipoScience, a diagnostic company pioneering an innovative new field of customized NMR diagnostics to advance the quality of patient care, specifically regarding metabolic, cardiovascular and other diseases, announced earlier today the recruitment of William Cromwell, M.D. to the position of … Continue reading →

Posted in Small Cap News | Leave a comment